Signal Explorer
10-K · 10-Q · 8-K · last 6 months · ← back to feed
Lantheus Holdings, Inc.
LNTH
Other
Merger Proxy Statement Disclosure
Other
Merger Proxy Statement Disclosure
Stock Option Grant Disclosed
Acquisition And Management Fees Disclosed
Core
Indication Expansion
Clinical Hold
Other
Rsu Psu Vesting Schedule Disclosed
Effective Tax Rate Reconciliation
Share Repurchase Activity Disclosed
Unrealized Gain Loss Disclosure
Fair Value Hierarchy Disclosure
Financing Activities Cash Flow Disclosure
Fast Track Designation Received
Convertible Debt Conversion
Ipo Net Proceeds Disclosure
Fast Track Granted
Liquidity Position Snapshot Disclosed
Share Withholding Tax Settlement
Convertible Notes Conversion Terms Disclosed
Core
Regulatory Designation Only
Biotech Risk
Orphan Drug Designation
Other
Liquidity Position Snapshot Disclosed
International Expansion
Merger Proxy Statement Disclosure
Form 8K Filing Disclosure
Free Cash Flow Metric Disclosed
Operating Income Year Over Year Increase
Core
Indication Expansion
Healthcare
Pricing Power Services
Other
Corporate Authority Representation
New York Jurisdiction Clause
Corporate Organization And Standing Representation
Sanctions Compliance Representation
Amendment Modification Waiver Clause
Board Committee Member Listing
Hazardous Materials Definition
Erisa Definition Or Compliance Statement
No Broker Fees Representation
Cause For Termination Defined
Share Withholding Tax Settlement
Change Of Control Definition
Successor Agent Appointment Provision
Confidential Information Return Obligation
Non Assignment Clause
Other
Merger Proxy Statement Disclosure
Board Fairness Determination
Director Continuity Stated
Kol Endorsement
Merger Acquisition Synergy Benefit Claim
Geographic Footprint Disclosure
Headcount Disclosure Standard
Core
Indication Expansion
Clinical Hold
Other
Share Repurchase Activity Disclosed
Unrealized Gain Loss Disclosure
Liquidity Position Snapshot Disclosed
Segment Aggregation Disclosure
Share Withholding Tax Settlement
Financing Activities Cash Flow Disclosure
Fast Track Designation Received
Priority Review Or Pdufa Disclosed
Employment Termination Upon Death
Severance Payment Obligation
Executive Severance Change Of Control
Fast Track Granted
Core
Regulatory Designation Only
Management Exodus
Clinical Trial Result
Other
International Expansion
Asset Sale Announced
Fast Track Granted
Priority Review Or Pdufa Disclosed
Fast Track Designation Received
Geographic Footprint Disclosure
Operating Margin Declining
Free Cash Flow Metric Disclosed
Biotech Risk
Accelerated Approval
Core
Near Term Regulatory Decision
Indication Expansion
Clinical Hold
Other
Performance Unit Award Establishment
Equity Award Plan Types Enumerated
Classified Board Director Election
Non Employee Director Compensation Disclosed
Equity Plan Amendment Restriction
Nonqualified Stock Option Exercise Or Grant
Rsu Psu Vesting Schedule Disclosed
Employment Termination Upon Death